scholarly journals Terpikhin for chronic inflammatory diseases of the female genital area Schwarz (Deut. Med. Woch., 1921, No. 52)

2021 ◽  
Vol 18 (3) ◽  
pp. 105-105
Author(s):  
V. G.

This remedy, offered by Oestgeich-Som, contains 15% ol. terebinthini, 0.5% quinine and anesthesin each, 84% ol. olivarum. Having applied it in 22 cases of perimetritis, salpingitis, oophoritis, infiltrates in the posterior Dоnglasen, etc., Schwarz (Deut. Med. Woch., 1921, No. 52) was very pleased with the results.

2013 ◽  
Vol 3 (2(8)) ◽  
pp. 67-70
Author(s):  
A.V. Semenyak ◽  
O.A. Andriets ◽  
R.V. Kormush ◽  
T.G. Farmazey

A clinical and laboratory examinationof 60 women with chronic inflammatory diseases ofthe female genital organs was provided. Pathogenicand conditionally pathogenic microorganisms in thevagina and the cervix, in the immune system probablereduction in lymphocytes, changes in the functionalstate of the reproductive system manifested significantdiminishing estrogen and progesterone were found.We suggested a specific antibiotic therapy on abackground of hormonal therapy - combined oralcontraceptives. Probable efficacy in three monthsis noted, which was showed by normalizationmicroorganisms in the vagina, absence of pathogenicorganisms and complaints of patients.


2021 ◽  
Vol 20 (2) ◽  
pp. 161-171
Author(s):  
Yu. A. Leibchik

A number of authors and researchers, sticking since 1916, have successfully used the so-called. protein therapy, namely, in the form of parenteral milk administration, for various inflammatory diseases of the uterine appendages, for uterine bleeding and for increasing milk secretion in women in childbirth.


1936 ◽  
Vol 32 (8) ◽  
pp. 954-960
Author(s):  
D. E. Shmundak

To restore the ability to work in women suffering from inflammatory diseases of the genital area, both conservative and radical methods of treatment are currently used.


1927 ◽  
Vol 23 (6-7) ◽  
pp. 746-746
Author(s):  
B. A. Arkhangelsky

The author found that low-dose x-ray therapy (the author used 15-20% NED) is a valuable way to treat inflammatory processes in the female genital area.


2015 ◽  
Vol 22 (2) ◽  
pp. 247-264 ◽  
Author(s):  
Nilanjan Ghosh ◽  
Asif Ali ◽  
Rituparna Ghosh ◽  
Shaileyee Das ◽  
Subhash C. Mandal ◽  
...  

2020 ◽  
Vol 26 (22) ◽  
pp. 2610-2619 ◽  
Author(s):  
Tarique Hussain ◽  
Ghulam Murtaza ◽  
Huansheng Yang ◽  
Muhammad S. Kalhoro ◽  
Dildar H. Kalhoro

Background: Inflammation is a complex response of the host defense system to different internal and external stimuli. It is believed that persistent inflammation may lead to chronic inflammatory diseases such as, inflammatory bowel disease, neurological and cardiovascular diseases. Oxidative stress is the main factor responsible for the augmentation of inflammation via various molecular pathways. Therefore, alleviating oxidative stress is effective a therapeutic option against chronic inflammatory diseases. Methods: This review article extends the knowledge of the regulatory mechanisms of flavonoids targeting inflammatory pathways in chronic diseases, which would be the best approach for the development of suitable therapeutic agents against chronic diseases. Results: Since the inflammatory response is initiated by numerous signaling molecules like NF-κB, MAPK, and Arachidonic acid pathways, their encountering function can be evaluated with the activation of Nrf2 pathway, a promising approach to inhibit/prevent chronic inflammatory diseases by flavonoids. Over the last few decades, flavonoids drew much attention as a potent alternative therapeutic agent. Recent clinical evidence has shown significant impacts of flavonoids on chronic diseases in different in-vivo and in-vitro models. Conclusion: Flavonoid compounds can interact with chronic inflammatory diseases at the cellular level and modulate the response of protein pathways. A promising approach is needed to overlook suitable alternative compounds providing more therapeutic efficacy and exerting fewer side effects than commercially available antiinflammatory drugs.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kathrin Beyer ◽  
Stein Atle Lie ◽  
Bodil Bjørndal ◽  
Rolf K. Berge ◽  
Asbjørn Svardal ◽  
...  

AbstractRheumatoid arthritis (RA) and periodontitis are chronic inflammatory diseases with several pathogenic pathways in common. Evidence supports an association between the diseases, but the exact underlying mechanisms behind the connection are still under investigation. Lipid, fatty acid (FA) and metabolic profile alterations have been associated with several chronic inflammatory diseases, including RA and periodontitis. Mitochondria have a central role in regulating cellular bioenergetic and whole-body metabolic homeostasis, and mitochondrial dysfunction has been proposed as a possible link between the two disorders. The aim of this cross-sectional study was to explore whole-blood FA, serum lipid composition, and carnitine- and choline derivatives in 78 RA outpatients with different degrees of periodontal inflammation. The main findings were alterations in lipid, FA, and carnitine- and choline derivative profiles. More specifically, higher total FA and total cholesterol concentrations were found in active RA. Elevated phospholipid concentrations with concomitant lower choline, elevated medium-chain acylcarnitines (MC-AC), and decreased ratios of MC-AC and long-chain (LC)-AC were associated with prednisolone medication. This may indicate an altered mitochondrial function in relation to the increased inflammatory status in RA disease. Our findings may support the need for interdisciplinary collaboration within the field of medicine and dentistry in patient stratification to improve personalized treatment. Longitudinal studies should be conducted to further assess the potential impact of mitochondrial dysfunction on RA and periodontitis.


Molecules ◽  
2021 ◽  
Vol 26 (6) ◽  
pp. 1704
Author(s):  
Diego Angosto-Bazarra ◽  
Cristina Molina-López ◽  
Alejandro Peñín-Franch ◽  
Laura Hurtado-Navarro ◽  
Pablo Pelegrín

Inflammasomes are immune cytosolic oligomers involved in the initiation and progression of multiple pathologies and diseases. The tight regulation of these immune sensors is necessary to control an optimal inflammatory response and recover organism homeostasis. Prolonged activation of inflammasomes result in the development of chronic inflammatory diseases, and the use of small drug-like inhibitory molecules are emerging as promising anti-inflammatory therapies. Different aspects have to be taken in consideration when designing inflammasome inhibitors. This review summarizes the different techniques that can be used to study the mechanism of action of potential inflammasome inhibitory molecules.


2021 ◽  
pp. 105253
Author(s):  
Pascal Richette ◽  
Matthieu Allez ◽  
Vincent Descamps ◽  
Lucas Perray ◽  
Simon Pilet ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document